A dual thyrointegrin antagonist and a method for treating an angiogenesis-mediated disorder and/or a hyperthyroidism disorders by introducing the dual thyrointegrin antagonist into animals (e.g., mammals, human beings). The dual thyrointegrin antagonist includes a chemical structure having a thyroid hormone antagonist and αvβ
3
integrin antagonist in the same molecule.
一种双重甲状腺整合素拮抗剂及其治疗介导血管生成障碍和/或甲状腺功能亢进症的方法,通过将双重甲状腺整合素拮抗剂引入动物(例如哺乳动物、人类)来实现。双重甲状腺整合素拮抗剂包括一种具有甲状腺激素拮抗剂和αvβ3整合素拮抗剂的
化学结构在同一分子中。